US Stock MarketDetailed Quotes

HCWB HCW Biologics

Watchlist
  • 0.333
  • -0.008-2.46%
Trading Mar 13 13:52 ET
14.82MMarket Cap-0.33P/E (TTM)

HCW Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-50.02%426.42K
-0.63%618.85K
2,590.14%1.13M
-57.72%2.84M
-1.31%1.32M
-52.84%853.1K
37.18%622.81K
-98.66%41.88K
6.72M
1.34M
Operating revenue
-50.02%426.42K
-0.63%618.85K
2,590.14%1.13M
-57.72%2.84M
-1.31%1.32M
-52.84%853.1K
37.18%622.81K
-98.66%41.88K
--6.72M
--1.34M
Cost of revenue
-49.71%341.14K
-12.73%438.44K
1,644.34%511.97K
-44.84%2.28M
-0.17%1.07M
-53.13%678.33K
74.93%502.4K
-97.79%29.35K
4.14M
1.07M
Gross profit
-51.20%85.29K
49.84%180.41K
4,805.03%614.75K
-78.33%560.36K
-5.84%252.65K
-51.69%174.78K
-27.81%120.41K
-99.30%12.53K
2.59M
268.3K
Operating expense
-28.12%3.78M
202.67%14.02M
50.91%8.11M
48.75%26.28M
85.68%11.02M
19.88%5.25M
25.91%4.63M
46.39%5.37M
32.15%17.67M
90.70%5.94M
Selling and administrative expenses
-28.47%2.52M
304.16%11.92M
94.16%5.92M
63.79%13.08M
29.24%3.56M
107.10%3.52M
74.42%2.95M
65.21%3.05M
60.55%7.99M
73.79%2.75M
-General and administrative expense
-28.47%2.52M
304.16%11.92M
94.16%5.92M
63.79%13.08M
29.24%3.56M
107.10%3.52M
74.42%2.95M
65.21%3.05M
60.55%7.99M
73.79%2.75M
Research and development costs
-28.82%1.19M
25.52%2.03M
-5.87%2.12M
-17.80%7.68M
-27.09%2.14M
-37.05%1.67M
-17.93%1.62M
26.05%2.26M
14.25%9.34M
97.53%2.93M
Depreciation amortization depletion
9.97%69.37K
2.81%66.62K
-3.08%67.08K
-21.18%266.76K
-69.17%78.31K
97.51%63.08K
282.51%64.8K
94.39%69.21K
54.92%338.46K
453.07%253.97K
-Depreciation and amortization
9.97%69.37K
2.81%66.62K
-3.08%67.08K
-21.18%266.76K
-69.17%78.31K
97.51%63.08K
282.51%64.8K
94.39%69.21K
54.92%338.46K
453.07%253.97K
Provision for doubtful accounts
----
----
----
--5.25M
----
----
----
----
--0
----
Operating profit
27.33%-3.69M
-206.75%-13.84M
-39.79%-7.49M
-70.55%-25.72M
-90.01%-10.77M
-26.33%-5.08M
-28.47%-4.51M
-185.01%-5.36M
-12.80%-15.08M
-82.08%-5.67M
Net non-operating interest income expense
-133.85%-223.36K
-67.17%-159.67K
0
-123.47%-283.04K
101.51%1.42K
-196.77%-95.51K
-95.51K
-93.44K
-126.66K
83.32%-94.48K
Non-operating interest expense
133.85%223.36K
67.17%159.67K
--0
123.47%283.04K
-101.51%-1.42K
196.77%95.51K
--95.51K
--93.44K
--126.66K
--94.48K
Other net income (expense)
-95.18%11.31K
-525.88%-1.28M
-93.32%25.6K
230.10%1.01M
-74.86%86.24K
70.55%234.75K
58,352.52%301.62K
317.31%383.32K
-39.70%304.74K
342.97K
Other non- operating income (expenses)
-95.18%11.31K
-525.88%-1.28M
-93.32%25.6K
230.10%1.01M
-74.86%86.24K
70.55%234.75K
58,352.52%301.62K
317.31%383.32K
-39.70%304.74K
--342.97K
Income before tax
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
Income tax
Net income
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
Net income continuous Operations
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
Minority interest income
Net income attributable to the parent company
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
Basic earnings per share
28.57%-0.1
-233.33%-0.4
-42.86%-0.2
-66.67%-0.7
-100.00%-0.3
-27.27%-0.14
-20.00%-0.12
-133.33%-0.14
39.13%-0.42
-69.07%-0.15
Diluted earnings per share
28.57%-0.1
-233.33%-0.4
-42.86%-0.2
-66.67%-0.7
-100.00%-0.3
-27.27%-0.14
-20.00%-0.12
-133.33%-0.14
39.13%-0.42
-69.07%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -50.02%426.42K-0.63%618.85K2,590.14%1.13M-57.72%2.84M-1.31%1.32M-52.84%853.1K37.18%622.81K-98.66%41.88K6.72M1.34M
Operating revenue -50.02%426.42K-0.63%618.85K2,590.14%1.13M-57.72%2.84M-1.31%1.32M-52.84%853.1K37.18%622.81K-98.66%41.88K--6.72M--1.34M
Cost of revenue -49.71%341.14K-12.73%438.44K1,644.34%511.97K-44.84%2.28M-0.17%1.07M-53.13%678.33K74.93%502.4K-97.79%29.35K4.14M1.07M
Gross profit -51.20%85.29K49.84%180.41K4,805.03%614.75K-78.33%560.36K-5.84%252.65K-51.69%174.78K-27.81%120.41K-99.30%12.53K2.59M268.3K
Operating expense -28.12%3.78M202.67%14.02M50.91%8.11M48.75%26.28M85.68%11.02M19.88%5.25M25.91%4.63M46.39%5.37M32.15%17.67M90.70%5.94M
Selling and administrative expenses -28.47%2.52M304.16%11.92M94.16%5.92M63.79%13.08M29.24%3.56M107.10%3.52M74.42%2.95M65.21%3.05M60.55%7.99M73.79%2.75M
-General and administrative expense -28.47%2.52M304.16%11.92M94.16%5.92M63.79%13.08M29.24%3.56M107.10%3.52M74.42%2.95M65.21%3.05M60.55%7.99M73.79%2.75M
Research and development costs -28.82%1.19M25.52%2.03M-5.87%2.12M-17.80%7.68M-27.09%2.14M-37.05%1.67M-17.93%1.62M26.05%2.26M14.25%9.34M97.53%2.93M
Depreciation amortization depletion 9.97%69.37K2.81%66.62K-3.08%67.08K-21.18%266.76K-69.17%78.31K97.51%63.08K282.51%64.8K94.39%69.21K54.92%338.46K453.07%253.97K
-Depreciation and amortization 9.97%69.37K2.81%66.62K-3.08%67.08K-21.18%266.76K-69.17%78.31K97.51%63.08K282.51%64.8K94.39%69.21K54.92%338.46K453.07%253.97K
Provision for doubtful accounts --------------5.25M------------------0----
Operating profit 27.33%-3.69M-206.75%-13.84M-39.79%-7.49M-70.55%-25.72M-90.01%-10.77M-26.33%-5.08M-28.47%-4.51M-185.01%-5.36M-12.80%-15.08M-82.08%-5.67M
Net non-operating interest income expense -133.85%-223.36K-67.17%-159.67K0-123.47%-283.04K101.51%1.42K-196.77%-95.51K-95.51K-93.44K-126.66K83.32%-94.48K
Non-operating interest expense 133.85%223.36K67.17%159.67K--0123.47%283.04K-101.51%-1.42K196.77%95.51K--95.51K--93.44K--126.66K--94.48K
Other net income (expense) -95.18%11.31K-525.88%-1.28M-93.32%25.6K230.10%1.01M-74.86%86.24K70.55%234.75K58,352.52%301.62K317.31%383.32K-39.70%304.74K342.97K
Other non- operating income (expenses) -95.18%11.31K-525.88%-1.28M-93.32%25.6K230.10%1.01M-74.86%86.24K70.55%234.75K58,352.52%301.62K317.31%383.32K-39.70%304.74K--342.97K
Income before tax 20.98%-3.9M-254.99%-15.28M-47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M
Income tax
Net income 20.98%-3.9M-254.99%-15.28M-47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M
Net income continuous Operations 20.98%-3.9M-254.99%-15.28M-47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M
Minority interest income
Net income attributable to the parent company 20.98%-3.9M-254.99%-15.28M-47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.98%-3.9M-254.99%-15.28M-47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M
Basic earnings per share 28.57%-0.1-233.33%-0.4-42.86%-0.2-66.67%-0.7-100.00%-0.3-27.27%-0.14-20.00%-0.12-133.33%-0.1439.13%-0.42-69.07%-0.15
Diluted earnings per share 28.57%-0.1-233.33%-0.4-42.86%-0.2-66.67%-0.7-100.00%-0.3-27.27%-0.14-20.00%-0.12-133.33%-0.1439.13%-0.42-69.07%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Vale SA
VALE
+1.56%
Strategy
MSTR
+1.09%
NVIDIA
NVDA
+0.81%
Petroleo Brasileiro SA Petrobras
PBR
+0.43%
Ecopetrol
EC
+0.31%

Unlock the Full List